Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ResMed Inc. (CHESS) Company Profile (ASX:RMD)

Consensus Ratings for ResMed Inc. (CHESS) (ASX:RMD) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: A$6.24

Analysts' Ratings History for ResMed Inc. (CHESS) (ASX:RMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/13/2014MorningstarDowngradeAccumulate -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/14/2014Deutsche BankReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
2/6/2014Deutsche BankReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
1/29/2014Deutsche BankReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
11/7/2013Goldman SachsReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Goldman SachsReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
10/23/2013Commonwealth BankUpgradeOutperform$5.80 -> $6.24ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013Goldman SachsReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
10/15/2013Commonwealth BankUpgradeOutperform$5.80 -> $6.24ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013Commonwealth BankUpgradeOutperform$5.80 -> $6.24ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2012 forward)